CJ: Thin Profits and a Falling Share Price Despite Steady Revenue Growth

Thesis

The data supports a picture of a large, steadily growing revenue base with a stable operating margin of around 5%. It does not show that this has reached shareholders: net margin is 0.1% and ROE is 0.9%. The trailing P/E of 79.9 reflects depressed earnings rather than a high price, while the P/B of 0.7 sits below book value. The stock has fallen 9.8% over three months and 26.1% over one year, and is only 10.0% above its 52-week low of ₩116,900. Investor flow, foreign ownership and short balance data are not available, so we cannot say who has been buying or selling.

Business overview

CJ is classified as a holding company on KOSPI. It was founded on 1953-08-01 and listed on 1973-06-29. The CEOs listed are 손경식 and 김홍기. There are 29,176,998 listed shares, giving a market cap of about ₩3.75T and an enterprise value of about ₩4.01T. Consolidated revenue rose from ₩34.5T in 2021 to ₩45.0T in 2025, with growth of 18.7% in 2022, 1.0% in 2023, 5.5% in 2024 and 3.1% in 2025. No segment breakdown is available in the data.

Financial analysis

These figures come from filed financial statements (DART). Trailing revenue to H1 2026 is ₩46.28T, operating income ₩2.37T (margin 5.1%) and net income ₩47.0B (margin 0.1%). For 2025, revenue was ₩45.02T, operating income ₩2.53T (5.6% margin) and net income ₩143.3B. Operating margin has stayed between 4.9% and 5.8% since 2021. Net income has fluctuated: ₩275.0B in 2021, ₩202.1B in 2022, ₩194.8B in 2023, ₩100.5B in 2024 and ₩143.3B in 2025. ROE has slid from 5.4% in 2021 to 0.9% on a trailing basis. Liabilities to equity is 176.1%. Cash is ₩2.20T against borrowings of ₩2.46T, so borrowings are slightly higher than cash. Free cash flow is positive at ₩2.82T.

Valuation

The trailing P/E is 79.9 and P/B is 0.7. The price-to-sales ratio is 0.1 and dividend yield is 0.1%. EV/EBITDA is not available. At the end of 2025 the P/E was 35 and P/B was 1.0, so the P/B has dropped while the P/E has risen as earnings weakened. Listed peers show P/E ratios from 4.0 (SK Square) to 9.9 (KB Financial) and P/B ratios from 0.8 to 2.4. SK, the closest holding company peer in the list, has P/E 4.9 and P/B 1.1. CJ's P/B is at the low end of the peer range, while its P/E is far above all of them. Those peers are mostly financial companies, so the comparison is only rough.

Catalysts

• The half-year report for June 2026 was filed on 2026-08-14 and showed the trailing profit figures used in this report.
• Several lawsuit filings and amendments (2026-08-14, 2026-09-02, 2026-09-21) may bring rulings that affect results, though their details are not in the data.
• Subsidiary debt guarantee decisions were filed on 2026-09-08 and twice on 2026-09-17, and could affect group financial exposure.
• A 'major management matter relevant to investors' and a 5%+ holding report were filed on 2026-10-02, and an insider shareholding report on 2026-10-06, but the contents are not provided.
• Trailing free cash flow of ₩2.82T could support debt reduction if sustained.

Risks

• Net margin of 0.1% and ROE of 0.9% show that very little operating profit reaches shareholders.
• Liabilities to equity of 176.1% and borrowings of ₩2.46T above cash of ₩2.20T leave the balance sheet leveraged.
• Repeated lawsuit filings and subsidiary debt guarantees point to legal and contingent liability exposure that cannot be sized from the data.
• The share price is down 26.1% over one year and near its 52-week low, which shows weak market sentiment.
• Investor flow, foreign ownership, short balance and news data are missing, which limits what can be said about market positioning.

Closing view

The data shows a business with growing revenue and a steady operating margin of about 5%, but weak and uneven bottom-line profit, modest returns and meaningful leverage. The P/B of 0.7 and a P/E of 79.9 tell different stories, and the gap comes from depressed net income. The recent filings point to legal and guarantee matters whose details are not given. Without flow data or news, the evidence is mixed and does not support a firm conclusion beyond these observations.

Model estimate of fair value

The valuation model has no estimate for this company yet (not enough data, or no positive value with the base case).

Report history

1. Oct 13, 2026InitiationCJ: Thin Profits and a Falling Share Price Despite Steady Revenue Growth